Immunotherapy and patients treated for cancer with microsatellite instability, Bulletin du Cancer, vol.104, issue.1, pp.42-51, 2017. ,
DOI : 10.1016/j.bulcan.2016.11.006
URL : https://hal.archives-ouvertes.fr/hal-01419557
A tailored approach to BRAF and MLH1 methylation testing in a universal screening program for Lynch syndrome, Modern Pathology, vol.31, issue.3, 2017. ,
DOI : 10.1200/JCO.2012.45.1674
promoter region methylation testing is an effective prescreen for Lynch Syndrome (HNPCC), Journal of Medical Genetics, vol.20, issue.(1 Pt 1), pp.789-96, 2014. ,
DOI : 10.1016/j.ccr.2011.07.003
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5159427/pdf
methylation with germline mismatch repair (MMR) gene mutation status: a literature review assessing utility of tumour features for MMR variant classification, Journal of Medical Genetics, vol.49, issue.3, pp.151-158, 2012. ,
DOI : 10.1136/jmedgenet-2011-100714
Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability, Cancer Res, vol.58, pp.3455-3460, 1998. ,
Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer, Journal of Clinical Oncology, vol.28, issue.20, pp.3219-3245, 2010. ,
DOI : 10.1200/JCO.2009.27.1825
Mutation and Mismatch Repair Status of the MOSAIC Study, Journal of Clinical Oncology, vol.33, issue.35, pp.4176-87, 2015. ,
DOI : 10.1200/JCO.2015.63.4238
Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO Study, Journal of the National Cancer Institute, vol.108, issue.7, 2016. ,
DOI : 10.1093/jnci/djv438
DNA Mismatch Repair Status and Colon Cancer Recurrence and Survival in Clinical Trials of 5-Fluorouracil-Based Adjuvant Therapy, JNCI Journal of the National Cancer Institute, vol.103, issue.11, pp.863-75, 2011. ,
DOI : 10.1093/jnci/djr153
Relationship between microsatellite instability, response and survival in palliative patients with colorectal cancer undergoing first-line chemotherapy, Anticancer Res, vol.23, pp.1773-1780, 2003. ,
Microsatellite instability and sensitivitiy to FOLFOX treatment in metastatic colorectal cancer, Anticancer Res, vol.27, pp.2715-2719, 2007. ,
Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer, Cancer, vol.28, issue.15 suppl, pp.4623-4655, 2011. ,
DOI : 10.1200/JCO.2009.23.3452
Deficient mismatch repair system in patients with sporadic advanced colorectal cancer, British Journal of Cancer, vol.154, issue.2, pp.266-73, 2009. ,
DOI : 10.1200/JCO.2003.03.123
URL : http://www.nature.com/bjc/journal/v100/n2/pdf/6604867a.pdf
Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor, Anticancer Research, vol.37, issue.1, pp.239-286, 2017. ,
DOI : 10.21873/anticanres.11313
Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies, Clinical Cancer Research, vol.20, issue.20, pp.5322-5352, 2014. ,
DOI : 10.1158/1078-0432.CCR-14-0332
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency, New England Journal of Medicine, vol.372, issue.26, pp.2509-2529, 2015. ,
DOI : 10.1056/NEJMoa1500596
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study, The Lancet Oncology, vol.18, issue.9, pp.10-1016, 2017. ,
DOI : 10.1016/S1470-2045(17)30422-9
Guidelines on Genetic Evaluation and Management of Lynch Syndrome, Diseases of the Colon & Rectum, vol.57, issue.8, pp.502-528, 2014. ,
DOI : 10.1097/DCR.000000000000000
Hereditary Colorectal Cancer Syndromes: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the Familial Risk???Colorectal Cancer: European Society for Medical Oncology Clinical Practice Guidelines, Journal of Clinical Oncology, vol.33, issue.2, pp.209-226, 2015. ,
DOI : 10.1200/JCO.2014.58.1322
Prognostic Significance of Defective Mismatch Repair and BRAF V600E in Patients with Colon Cancer, Clinical Cancer Research, vol.14, issue.11, pp.3408-3423, 2008. ,
DOI : 10.1158/1078-0432.CCR-07-1489
Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab, JAMA Oncology, vol.2, issue.5, p.643, 2016. ,
DOI : 10.1001/jamaoncol.2015.5225
URL : https://hal.archives-ouvertes.fr/hal-01427989
Multicenter retrospective analysis of metastatic colorectal cancer (CRC) with high-level microsatellite instability (MSI-H), Annals of Oncology, vol.25, issue.5 ,
DOI : 10.1093/annonc/mdu100
in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial, Journal of Clinical Oncology, vol.28, issue.3, pp.466-74, 2010. ,
DOI : 10.1200/JCO.2009.23.3452
-Mutant???Like Population of Patients With Colon Cancer, Journal of Clinical Oncology, vol.30, issue.12, pp.1288-95, 2012. ,
DOI : 10.1200/JCO.2011.39.5814
The consensus molecular subtypes of colorectal cancer, Nature Medicine, vol.228, issue.11, pp.1350-1356, 2015. ,
DOI : 10.1186/gb-2004-5-10-r80
Familial risk-colorectal cancer: ESMO Clinical Practice Guidelines, Ann Oncol, vol.24, 2013. ,
Programmed death-1 blockade in mismatch repair deficient colorectal cancer, J Clin Oncol, vol.34, 2016. ,